The Use of Recombinant Activated Factor VII for Refractory Bleeding Post Complex Cardiothoracic Surgery

Anaesthesia and Intensive Care- Australia

doi 10.1177/0310057x0603400115

Full Text

Abstract

Available in

Categories

Intensive Care Medicine

Date

February 1, 2006

Authors

M Chinthamuneedi

Publisher

SAGE Publications

Related search

Intraoperative Use of Recombinant Activated Factor VII During Complex Aortic Surgery

Journal of Thoracic and Cardiovascular Surgery

Respiratory Medicine

Cardiovascular Medicine

English

Recombinant Activated Factor VII (rFVIIa) Treatment of Refractory Bleeding in Cardiac Surgical Patients

Journal of Anesthesia & Clinical Research

English

Recombinant Activated Factor VII and Aortic Surgery

European Journal of Vascular and Endovascular Surgery

Cardiovascular Medicine

English

Use of Recombinant Factor VII in Cardiac Surgery

Recent Patents on Cardiovascular Drug Discovery

English

Successful Management of Severe Bleeding After Redo Cardiac Transplantation With Recombinant Activated Factor VII

Journal of Clinical Case Reports

English

Effect of Recombinant Activated Factor VII in Critical Bleeding: Clinical Experience of a Single Center

Clinical and Applied Thrombosis/Hemostasis

English

Preemptive Use of Recombinant Activated Factor VII: Many Questions but Few Answers

Canadian Journal of Anaesthesia

English

Elective Surgery on Factor VIII Inhibitor Patients Using Continuous Infusion of Recombinant Activated Factor VII

Thrombosis and Haemostasis

English

Successful Use of Recombinant Activated Factor VII for Postoperative Associated Haemorrhage: A Case Report

English